Report cover image

Premenstrual Dysphoric Disorder - Pipeline Insight, 2024

Publisher DelveInsight
Published Apr 01, 2024
Length 40 Pages
SKU # DEL18679977

Description

Premenstrual Dysphoric Disorder - Pipeline Insight, 2024



DelveInsight’s, “Premenstrual Dysphoric Disorder (PMDD) – Pipeline Insight, 2024,” report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in Premenstrual Dysphoric Disorder (PMDD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Geography Covered
  • Global coverage
Premenstrual Dysphoric Disorder (PMDD) Understanding

Premenstrual Dysphoric Disorder (PMDD): Overview

Premenstrual dysphoric disorder (PMDD) is similar to premenstrual syndrome (PMS) that occurs due to the changes in the hormone levels right a week or two before the start of the period. It been established that the hormone levels tend to fall after ovulation resulting in PMDD. The exact cause of this condition isn’t known yet. It affects about 5% women of childbearing age.

Symptoms

Symptoms of PMDD include feelings of anxiety and tension, panic attacks, lasting anger or irritability that may affect others, tiredness or low energy, mood swings, feelings of despair, sadness, and suicidal thoughts, trouble sleeping, binge eating, losing interest in daily life and relationships, and physical symptoms, such as breast tenderness, bloating, muscle or joint pain, and headaches.

Diagnosis

For the diagnosis of PMDD, a complete physical and pelvic exam is conducted along with thorough medical history. As most of the symptoms associated with this disease are related to mental health, the diagnosis may also be made based on those where mental health-related symptoms during the menstrual cycle are observed and listed over several months.

Treatment

Treatment of PMDD becomes quite imperative as it can severely affect the quality of life. Some of the ways to treat PMDD are birth control pills, changes in lifestyle, selective serotonin reuptake inhibitors, stress management, anti-inflammatory medicines, and vitamin supplements

Premenstrual Dysphoric Disorder (PMDD) Emerging Drugs Chapters

This segment of the Premenstrual Dysphoric Disorder (PMDD) report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases.

Premenstrual Dysphoric Disorder (PMDD) Emerging Drugs
  • UC-1010: Asarina Pharma
UC-1010, also known as Sepranolone, is in the Phase II stage of drug development. It belongs to the class of antidepressants and work as GABA-A receptor antagonists. The company completed the Phase IIB trial for PMDD in October 2020 in four countries.

Further product details are provided in the report……..

Premenstrual Dysphoric Disorder (PMDD): Therapeutic Assessment

This segment of the report provides insights about the different Premenstrual Dysphoric Disorder (PMDD) drugs segregated based on following parameters that define the scope of the report, such as:
  • Major Players in Premenstrual Dysphoric Disorder (PMDD)
There are approx. 2+ key companies which are developing the therapies for Premenstrual Dysphoric Disorder (PMDD). The companies which have their Premenstrual Dysphoric Disorder (PMDD) drug candidates in the mid to advanced stage, i.e. phase III and Phase II include, Asarina Pharma and others.

Phases

DelveInsight’s report covers around 10+ products under different phases of clinical development like
  • Mid-stage products (Phase II and Phase I/II)
  • Early-stage products (Phase I/II and Phase I) along with the details of
  • Pre-clinical and Discovery stage candidates
  • Discontinued & Inactive candidates
  • Route of Administration
Premenstrual Dysphoric Disorder (PMDD) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
  • Subcutaneous
  • Intravenous
  • Oral
  • Intramuscular
  • Molecule Type
Products have been categorized under various Molecule types such as
  • Small molecules
  • Natural metabolites
  • Monoclonal antibodies
  • Product Type
Drugs have been categorized under various product types like Mono, Combination and Mono/Combination.

Premenstrual Dysphoric Disorder (PMDD): Pipeline Development Activities

The report provides insights into different therapeutic candidates in phase II, I, preclinical and discovery stage. It also analyses Premenstrual Dysphoric Disorder (PMDD) therapeutic drugs key players involved in developing key drugs.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing along with a thorough therapeutic assessment of emerging Premenstrual Dysphoric Disorder (PMDD) drugs.

Report Highlights
  • The companies and academics are working to assess challenges and seek opportunities that could influence Premenstrual Dysphoric Disorder (PMDD) R&D. The therapies under development are focused on novel approaches to treat/improve Premenstrual Dysphoric Disorder (PMDD).
Premenstrual Dysphoric Disorder (PMDD) Report Insights
  • Premenstrual Dysphoric Disorder (PMDD) Pipeline Analysis
  • Therapeutic Assessment
  • Unmet Needs
  • Impact of Drugs
Premenstrual Dysphoric Disorder (PMDD) Report Assessment
  • Pipeline Product Profiles
  • Therapeutic Assessment
  • Pipeline Assessment
  • Inactive drugs assessment
  • Unmet Needs
Key Questions

Current Treatment Scenario and Emerging Therapies:
  • How many companies are developing Premenstrual Dysphoric Disorder (PMDD) drugs?
  • How many Premenstrual Dysphoric Disorder (PMDD) drugs are developed by each company?
  • How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Premenstrual Dysphoric Disorder (PMDD)?
  • What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Premenstrual Dysphoric Disorder (PMDD) therapeutics?
  • What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
  • What are the clinical studies going on for Premenstrual Dysphoric Disorder (PMDD) and their status?
  • What are the key designations that have been granted to the emerging drugs?
Key Players
  • Asarina Pharma
Key Products
  • UC-1010

Table of Contents

40 Pages
Introduction
Executive Summary
Premenstrual Dysphoric Disorder (PMDD): Overview
Causes
Mechanism of Action
Signs and Symptoms
Diagnosis
Disease Management
Pipeline Therapeutics
Comparative Analysis
Therapeutic Assessment
Assessment by Product Type
Assessment by Stage and Product Type
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
Premenstrual Dysphoric Disorder (PMDD) – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Premenstrual Dysphoric Disorder (PMDD) companies’ collaborations, Licensing, Acquisition -Deal Value Trends
Premenstrual Dysphoric Disorder (PMDD) Collaboration Deals
Company-Company Collaborations (Licensing / Partnering) Analysis
Company-University Collaborations (Licensing / Partnering) Analysis
Late Stage Products (Phase III)
Comparative Analysis
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
Comparative Analysis
UC-1010: Asarina Pharma
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report…..
Pre-clinical and Discovery Stage Products
Comparative Analysis
Product Description
Research and Development
Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
Comparative Analysis
Premenstrual Dysphoric Disorder (PMDD) Key Companies
Premenstrual Dysphoric Disorder (PMDD) Key Products
Premenstrual Dysphoric Disorder (PMDD)- Unmet Needs
Premenstrual Dysphoric Disorder (PMDD)- Market Drivers and Barriers
Premenstrual Dysphoric Disorder (PMDD)- Future Perspectives and Conclusion
Premenstrual Dysphoric Disorder (PMDD) Analyst Views
Premenstrual Dysphoric Disorder (PMDD) Key Companies
Appendix

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us